Intra-Cellular Therapies Inc
NASDAQ:ITCI

Watchlist Manager
Intra-Cellular Therapies Inc Logo
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Watchlist
Price: 89.09 USD 0.99% Market Closed
Market Cap: 9.4B USD
Have any thoughts about
Intra-Cellular Therapies Inc?
Write Note

Net Margin
Intra-Cellular Therapies Inc

-14.1%
Current
-133%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-14.1%
=
Net Income
-86.4m
/
Revenue
613.7m

Net Margin Across Competitors

Country US
Market Cap 9.4B USD
Net Margin
-14%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 756.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 364.1B USD
Net Margin
17%
Country US
Market Cap 248.4B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for Intra-Cellular Therapies Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-14.1%
=
Net Income
-86.4m
/
Revenue
613.7m
What is the Net Margin of Intra-Cellular Therapies Inc?

Based on Intra-Cellular Therapies Inc's most recent financial statements, the company has Net Margin of -14.1%.